microRNA information: hsa-miR-369-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-369-3p | miRbase |
| Accession: | MIMAT0000721 | miRbase |
| Precursor name: | hsa-mir-369 | miRbase |
| Precursor accession: | MI0000777 | miRbase |
| Symbol: | MIR369 | HGNC |
| RefSeq ID: | NR_029862 | GenBank |
| Sequence: | AAUAAUACAUGGUUGAUCUUU |
Reported expression in cancers: hsa-miR-369-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-369-3p | NA | NA | "NA ......" | NA | NA |
| hsa-miR-369-3p | " ......" |
Reported cancer pathway affected by hsa-miR-369-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|
Reported cancer prognosis affected by hsa-miR-369-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-369-3p | esophageal cancer | poor survival | "miRNA high-throughput sequencing data were downloa ......" | 26498375 |
Reported gene related to hsa-miR-369-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-369-3p | PER3 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; SARC; STAD | MirTarget | TCGA BLCA -0.126; TCGA BRCA -0.101; TCGA CESC -0.118; TCGA COAD -0.287; TCGA HNSC -0.098; TCGA LGG -0.051; TCGA LIHC -0.064; TCGA SARC -0.078; TCGA STAD -0.423 |
hsa-miR-369-3p | FRMD3 | 9 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.325; TCGA BRCA -0.195; TCGA COAD -0.31; TCGA ESCA -0.488; TCGA LIHC -0.127; TCGA LUAD -0.121; TCGA LUSC -0.356; TCGA PAAD -0.179; TCGA STAD -0.176 |
hsa-miR-369-3p | VPS13A | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; SARC; STAD | miRNATAP | TCGA BLCA -0.142; TCGA BRCA -0.12; TCGA COAD -0.113; TCGA ESCA -0.175; TCGA HNSC -0.08; TCGA LUAD -0.073; TCGA LUSC -0.089; TCGA SARC -0.162; TCGA STAD -0.161 |
hsa-miR-369-3p | FZD5 | 9 cancers: BRCA; ESCA; HNSC; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget; PITA; miRNATAP | TCGA BRCA -0.083; TCGA ESCA -0.308; TCGA HNSC -0.105; TCGA LUAD -0.084; TCGA LUSC -0.098; TCGA PAAD -0.175; TCGA PRAD -0.154; TCGA STAD -0.122; TCGA UCEC -0.08 |
hsa-miR-369-3p | USP54 | 9 cancers: BRCA; COAD; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BRCA -0.072; TCGA COAD -0.105; TCGA HNSC -0.084; TCGA LGG -0.082; TCGA LUAD -0.081; TCGA LUSC -0.097; TCGA PAAD -0.115; TCGA PRAD -0.142; TCGA STAD -0.138 |
hsa-miR-369-3p | RABGAP1L | 10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; STAD | miRNATAP | TCGA BRCA -0.079; TCGA CESC -0.062; TCGA COAD -0.192; TCGA ESCA -0.11; TCGA HNSC -0.061; TCGA LUAD -0.065; TCGA LUSC -0.164; TCGA PAAD -0.119; TCGA SARC -0.1; TCGA STAD -0.097 |
Enriched cancer pathways of putative targets